Skip to main
University-wide Navigation

Mid South I-Corps Hub

Markey’s Vanderford named AACE Fellow

UK Markey Cancer Center researcher Nathan Vanderford has been named a fellow of the American Association for Cancer Education (AACE), joining an elite group of cancer education leaders.

Markey study highlights brain-preserving radiation technique for rare cancer

A recent UK study highlights a radiation therapy technique that could offer hope for patients with a rare and aggressive form of brain cancer.

UK researchers explore use of nanoparticles to improve cancer therapy

Researchers at UK are exploring new ways to use nanoparticles in combination with other materials as an innovative approach to cancer therapy.

Markey helps lead development of new Ky. Cancer Action Plan

The latest Kentucky Cancer Action Plan provides a comprehensive blueprint for reducing cancer burden throughout Kentucky by 2030.

Markey research shows success in national smoking assessment program

Jessica Burris led research that shows the success of a national quality improvement program to increase rates of smoking assessment among cancer centers.

UK researchers expand access to radon mitigation in Kentucky with $2.6 million grant

Researchers form multiple organizations at UK and around the commonwealth are working together to learn how best to protect the public from radon exposure.

Markey researchers discover new treatment target for triple-negative breast cancer

UK Markey Cancer Center researchers identified a protein that could be key to developing new treatments for triple-negative breast cancer.

Lt. Gov. Coleman highlights cancer education and prevention, Markey programs

Kentucky Lt. Gov. Jacqueline Coleman visited Albert B. Chandler Hospital to recognize the importance of cancer education and prevention in the Commonwealth and highlight two innovative UK Markey Cancer Center programs.

Markey forges global alliance for cancer research

The University of Kentucky Markey Cancer Center's Global Cancer Consortium is an innovative partnership that's transforming cancer research and care across borders.